Malignant Bone Marrow Neoplasm — Trials

Malignant Bone Marrow Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,609 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,034
Recruiting: 591
Ph III recruiting: 61
Growth YoY: +8.6%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (799)

clinicaltrialsPublishedShowing 101–150 of 190 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07372885	GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia(GRACE)	not yet recruiting	Phase 1 / Phase 2	50	University of ManchesterOTHER	1	Mar 11, 2026	clinicaltrials
NCT07463768	Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.(MIVONU)	not yet recruiting	Phase 2	60	French Innovative Leukemia Organisation